Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q42813847)
Watch
English
An unmet need: tailoring extended adjuvant endocrine therapy
scientific article published on 19 November 2013
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMC publication ID
3859956
retrieved
7 November 2017
editorial
0 references
title
An unmet need: tailoring extended adjuvant endocrine therapy
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
3859956
retrieved
7 November 2017
author
Luca Gianni
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
3859956
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24253504%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 June 2020
author name string
G Bianchini
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
3859956
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24253504%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 June 2020
language of work or name
English
0 references
publication date
19 November 2013
1 reference
stated in
Europe PubMed Central
PMC publication ID
3859956
retrieved
7 November 2017
published in
British Journal of Cancer
1 reference
stated in
Europe PubMed Central
PMC publication ID
3859956
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24253504%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 June 2020
volume
109
1 reference
stated in
Europe PubMed Central
PMC publication ID
3859956
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24253504%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 June 2020
issue
12
1 reference
stated in
Europe PubMed Central
PMC publication ID
3859956
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24253504%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 June 2020
page(s)
2951-2953
1 reference
stated in
Europe PubMed Central
PMC publication ID
3859956
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24253504%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 June 2020
cites work
The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patients.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859956
retrieved
27 May 2018
Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859956
retrieved
27 May 2018
Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859956
retrieved
27 May 2018
Factors predicting late recurrence for estrogen receptor-positive breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859956
retrieved
27 May 2018
Prediction of late disease recurrence and extended adjuvant letrozole benefit by the HOXB13/IL17BR biomarker
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859956
retrieved
27 May 2018
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859956
retrieved
27 May 2018
Longer-term outcomes of letrozole versus placebo after 5 years of tamoxifen in the NCIC CTG MA.17 trial: analyses adjusting for treatment crossover
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859956
retrieved
27 May 2018
Estrogen receptor (ESR1) mRNA expression and benefit from tamoxifen in the treatment and prevention of estrogen receptor-positive breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859956
retrieved
27 May 2018
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859956
retrieved
27 May 2018
Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859956
retrieved
27 May 2018
Prognostic utility of HOXB13:IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859956
retrieved
27 May 2018
Estrogen receptor and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the Tamoxifen and Exemestane Adjuvant Multinational trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859956
retrieved
27 May 2018
A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859956
retrieved
27 May 2018
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859956
retrieved
27 May 2018
Supervised risk predictor of breast cancer based on intrinsic subtypes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859956
retrieved
27 May 2018
Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: intention-to-treat analysis of the National Surgical Adjuvant Breast And Bowel Project B-33 trial.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859956
retrieved
27 May 2018
Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859956
retrieved
27 May 2018
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859956
retrieved
27 May 2018
Breast cancer index identifies early-stage estrogen receptor-positive breast cancer patients at risk for early- and late-distant recurrence
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859956
retrieved
16 August 2018
A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859956
retrieved
16 August 2018
Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859956
retrieved
16 August 2018
Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup trial MA.17.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859956
retrieved
16 August 2018
Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859956
retrieved
16 August 2018
A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3859956
retrieved
16 August 2018
Anatomy and biology: two complementary sides of breast cancer prognostication
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/24253504
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Quality of health care delivered to adults in the United States
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBJC.2013.707
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1038/BJC.2013.707
1 reference
stated in
Europe PubMed Central
PMC publication ID
3859956
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24253504%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 June 2020
PMC publication ID
3859956
1 reference
stated in
Europe PubMed Central
PMC publication ID
3859956
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24253504%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 June 2020
PubMed publication ID
24253504
1 reference
stated in
Europe PubMed Central
PMC publication ID
3859956
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24253504%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 June 2020
ResearchGate publication ID
258766698
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
